Tag: ABX464

July 2, 2020 Off

Abivax starts testing ABX464 with older Covid-19 patients

By Dino Mustafić

Abivax has treated the first patient in its Phase 2b/3 study of ABX464 in COVID-19 patients at the University Hospital Center in Nice, France (CHU Nice) in a randomized, double-blind, placebo-controlled study, to see the the effects of early treatment in 1034 Covid-19 older or high-risk patients.